Fidaxomicin (Dificid) for Clostridium difficile infection.

Name: Work Video:
Duration: 3 min 30 s
Description: Fidaxomicin is effective for the treatment of C. difficile infection, but it is much more expensive than traditional therapy. Until it is known that the benefits outweigh the significant cost, metronidazole or oral vancomycin is the preferred treatment for most patients.
Dhiren Patel; Jennifer D. Goldman
{'id': 'https://openalex.org/W2417186599', 'doi': None, 'title': 'Fidaxomicin (Dificid) for Clostridium difficile infection.', 'display_name': 'Fidaxomicin (Dificid) for Clostridium difficile infection.', 'publication_year': 2011, 'publication_date': '2011-09-19', 'ids': {'openalex': 'https://openalex.org/W2417186599', 'mag': '2417186599', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21921871'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21921871', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044001788', 'display_name': 'Dhiren Patel', 'orcid': 'https://orcid.org/0000-0003-4611-0814'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Dhiren Patel', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5052956709', 'display_name': 'Jennifer D. Goldman', 'orcid': 'https://orcid.org/0000-0002-9617-3998'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jennifer D. Goldman-Levine', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.16, 'has_fulltext': False, 'cited_by_count': 7, 'citation_normalized_percentile': {'value': 0.597202, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '53', 'issue': '1373', 'first_page': '73', 'last_page': '4'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11288', 'display_name': 'Clostridium difficile and Clostridium perfringens research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11288', 'display_name': 'Clostridium difficile and Clostridium perfringens research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13569', 'display_name': 'Microscopic Colitis', 'score': 0.9884, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10365', 'display_name': 'Gastrointestinal motility and disorders', 'score': 0.9606, 'subfield': {'id': 'https://openalex.org/subfields/2715', 'display_name': 'Gastroenterology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fidaxomicin', 'display_name': 'Fidaxomicin', 'score': 0.9806578}, {'id': 'https://openalex.org/keywords/c-difficile', 'display_name': 'C difficile', 'score': 0.69382215}, {'id': 'https://openalex.org/keywords/clostridium-infections', 'display_name': 'Clostridium Infections', 'score': 0.6486126}], 'concepts': [{'id': 'https://openalex.org/C2781342628', 'wikidata': 'https://www.wikidata.org/wiki/Q5446672', 'display_name': 'Fidaxomicin', 'level': 5, 'score': 0.9806578}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9766016}, {'id': 'https://openalex.org/C2994496256', 'wikidata': 'https://www.wikidata.org/wiki/Q27031090', 'display_name': 'Clostridium difficile', 'level': 3, 'score': 0.93621385}, {'id': 'https://openalex.org/C3019428505', 'wikidata': 'https://www.wikidata.org/wiki/Q574905', 'display_name': 'C difficile', 'level': 4, 'score': 0.69382215}, {'id': 'https://openalex.org/C2908810495', 'wikidata': 'https://www.wikidata.org/wiki/Q327663', 'display_name': 'Clostridium Infections', 'level': 4, 'score': 0.6486126}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.5057895}, {'id': 'https://openalex.org/C2778980435', 'wikidata': 'https://www.wikidata.org/wiki/Q424027', 'display_name': 'Vancomycin', 'level': 4, 'score': 0.13038585}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.118297756}, {'id': 'https://openalex.org/C523546767', 'wikidata': 'https://www.wikidata.org/wiki/Q10876', 'display_name': 'Bacteria', 'level': 2, 'score': 0.100141615}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C2779489039', 'wikidata': 'https://www.wikidata.org/wiki/Q188121', 'display_name': 'Staphylococcus aureus', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000617', 'descriptor_name': 'Aminoglycosides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000900', 'descriptor_name': 'Anti-Bacterial Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016360', 'descriptor_name': 'Clostridioides difficile', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D004761', 'descriptor_name': 'Enterocolitis, Pseudomembranous', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000617', 'descriptor_name': 'Aminoglycosides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000617', 'descriptor_name': 'Aminoglycosides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000617', 'descriptor_name': 'Aminoglycosides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000900', 'descriptor_name': 'Anti-Bacterial Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000900', 'descriptor_name': 'Anti-Bacterial Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000900', 'descriptor_name': 'Anti-Bacterial Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004761', 'descriptor_name': 'Enterocolitis, Pseudomembranous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077732', 'descriptor_name': 'Fidaxomicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012307', 'descriptor_name': 'Risk Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21921871', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.77, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 3, 'referenced_works': ['https://openalex.org/W2113556993', 'https://openalex.org/W2144282350', 'https://openalex.org/W2165050668'], 'related_works': ['https://openalex.org/W71505647', 'https://openalex.org/W4243204124', 'https://openalex.org/W4233410387', 'https://openalex.org/W297132856', 'https://openalex.org/W2908895064', 'https://openalex.org/W2753736076', 'https://openalex.org/W2320093550', 'https://openalex.org/W2167386325', 'https://openalex.org/W2112668354', 'https://openalex.org/W1581800443'], 'abstract_inverted_index': {'Fidaxomicin': [0], 'is': [1, 12, 21, 34], 'effective': [2], 'for': [3, 38], 'the': [4, 24, 27, 35], 'treatment': [5, 37], 'of': [6], 'C.': [7], 'difficile': [8], 'infection,': [9], 'but': [10], 'it': [11, 20], 'much': [13], 'more': [14], 'expensive': [15], 'than': [16], 'traditional': [17], 'therapy.': [18], 'Until': [19], 'known': [22], 'that': [23], 'benefits': [25], 'outweigh': [26], 'significant': [28], 'cost,': [29], 'metronidazole': [30], 'or': [31], 'oral': [32], 'vancomycin': [33], 'preferred': [36], 'most': [39], 'patients.': [40]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2417186599', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}], 'updated_date': '2024-12-16T02:14:26.532765', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
